Sitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study

The cerebrovascular safety and efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus (T2DM) with ischemic stroke remains uncertain. The aim of this study was to assess the efficacy and safety of sitagliptin in patients with T2DM with recent ischemic s...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Medicine (Baltimore)
Auteurs principaux: Chen, Dong-Yi, Wang, Szu-Heng, Mao, Chun-Tai, Tsai, Ming-Lung, Lin, Yu-Sheng, Su, Feng-Chieh, Chou, Chung-Chuan, Wen, Ming-Shien, Wang, Chun-Chieh, Hsieh, I-Chang, Hung, Kuo-Chun, Cherng, Wen-Jin, Chen, Tien-Hsing
Format: Artigo
Langue:Inglês
Publié: Wolters Kluwer Health 2015
Sujets:
5300
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4617065/
https://ncbi.nlm.nih.gov/pubmed/26181549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001128
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires